3' UTR 多态 rs1054564 与糖尿病和亚临床动脉样硬化有关
Montse Guardiola1,2,3,4, Josefa Girona1,2,3,4, Emma Barroso4,5,6,7
1Research Unit on Lipids and Atherosclerosis, Universitat Rovira i Virgili, 43201 Reus, Spain.
International journal of molecular sciences
|November 27, 2024
概括
生长差异化因子15 (GDF15) 的遗传变异会影响代谢健康. GDF15 rs1054564 SNP与糖尿病和动脉样硬化风险的增加有关,为这些疾病提供了潜在的生物标志物.
科学领域:
- 遗传学和分子生物学
- 代谢性疾病研究研究
- 心血管疾病病因学 心血管疾病病因学
背景情况:
- 增长分化因子15 (GDF15) 是一种细胞因子,与各种代谢疾病有关.
- 特定的GDF15遗传变异对代谢障碍和动脉样硬化的影响仍然在很大程度上未被描述.
研究的目的:
- 调查GDF15单核酸多态 (SNPs) 和代谢变化 (包括亚临床动脉样硬化) 之间的相关性.
- 为了确定GDF15SNP是否与血清GDF15水平和临床健康参数相关.
主要方法:
- 一项横截面研究分析了153名来自代谢患者队列的参与者.
- 使用聚合酶链反应 (PCR) 进行了三种GDF15SNP (rs888663,rs1054564,rs1059369) 的基因定型.
- 统计分析检查了SNP,血清GDF15水平和糖尿病和喉斑块存在等临床变量之间的关系.
主要成果:
- 在GDF15 rs1054564 SNP中,健康个体和患有脂质变化的个体之间呈现出差异分布.
- 与野生型携带者相比,RS1054564变种的携带者显示血清GDF15水平明显升高.
- Rs1054564 变种携带者患糖尿病和动脉样硬化性心血管斑块的患病率更高,独立于混因素.
结论:
- GDF15 rs1054564多态性与血清GDF15水平的增加有关.
- 这种特定的GDF15变体是糖尿病和亚临床动脉样硬化的可能性的潜在预测生物标志物.
相关概念视频
Diabetes Mellitus: Type 2 and Gestational
2.2K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.2K
Genome-wide Association Studies-GWAS
12.5K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
12.5K
Diabetes Mellitus: Overview and Type I Subtype
2.4K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.4K
Diabetes: Symptoms, Diagnosis, and Complications
506
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
506
Pathophysiology of Diabetes
868
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
868


